Yukihiro Saito Selected Research

Insulin Resistance

3/2022

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukihiro Saito Research Topics

Disease

5	Heart Failure 01/2023 - 08/2011
4	Pulmonary Arterial Hypertension 07/2023 - 01/2012
4	Hypoxia (Hypoxemia) 07/2023 - 11/2007
3	Fibrosis (Cirrhosis) 05/2019 - 01/2019
3	Hypertrophy 05/2019 - 08/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 03/2022
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2023 - 01/2019
2	Amyloidosis 01/2023 - 12/2021
2	Neoplasms (Cancer) 01/2023 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Aortic Valve Stenosis (Aortic Stenosis) 02/2021 - 01/2021
2	Chronic Limb-Threatening Ischemia 07/2020 - 01/2018
2	5 Familial Hemophagocytic Lymphohistiocytosis 01/2020 - 01/2013
2	Hyperplasia 01/2020 - 01/2013
2	Peripheral Arterial Disease 06/2019 - 10/2011
2	Cardiomegaly (Heart Hypertrophy) 05/2019 - 01/2019
2	Body Weight (Weight, Body) 05/2019 - 01/2019
2	Infections 05/2018 - 02/2018
2	Ischemia 10/2014 - 10/2011
2	Lymphedema (Milroy Disease) 01/2013 - 09/2006
1	Infarction (Infarctions) 02/2024
1	Fabry Disease (Fabry's Disease) 05/2023
1	Calcinosis 01/2023
1	Insulin Resistance 03/2022
1	Cardiotoxicity 01/2022
1	Rupture 01/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Immunoglobulin Light-chain Amyloidosis 12/2021
1	Stroke (Strokes) 07/2020
1	Diabetes Mellitus 01/2020
1	Hypersensitivity (Allergy) 02/2018
1	Arteriosclerosis Obliterans 01/2018
1	Vascular Calcification 08/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Right Ventricular Hypertrophy 05/2015
1	Pulmonary Hypertension 05/2015

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 07/2023 - 12/2021
2	Sodium-Glucose Transport ProteinsIBA 03/2022 - 05/2019
2	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022 - 05/2019
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
2	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2019
2	AntioxidantsIBA 01/2022 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2013
2	Adenosine Monophosphate (AMP)IBA 01/2020 - 01/2013
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 01/2013
2	MAP-kinase-activated kinase 3IBA 01/2020 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2019 - 01/2019
2	Eicosapentaenoic AcidIBA 08/2017 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 11/2007
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013 - 09/2006
1	Pyruvic Acid (Pyruvate)IBA 07/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	Oxidoreductases (Dehydrogenase)IBA 07/2023
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 07/2023
1	Adenosine Triphosphate (ATP)IBA 07/2023
1	agalsidase alfaIBA 05/2023
1	EnzymesIBA 05/2023
1	GalactosidasesIBA 05/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Technetium Tc 99m PyrophosphateIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	PPAR alphaIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2022
1	CatalaseIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	OligodeoxyribonucleotidesIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Collagen Type IV (Type IV Collagen)IBA 05/2019
1	KetonesIBA 05/2019
1	Natriuretic PeptidesIBA 05/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2019
1	SaltsIBA 05/2019
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 05/2019
1	ChemokinesIBA 01/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019
1	sacubitrilIBA 01/2019
1	Valsartan (Vals)FDA Link 01/2019
1	EndonucleasesIBA 01/2019
1	DNA Repair EnzymesIBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	MetalsIBA 02/2018
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017
1	MonocrotalineIBA 05/2015
1	Imatinib Mesylate (Gleevec)FDA Link 05/2015
1	Platelet-Derived Growth FactorIBA 05/2015

Therapy/Procedure

5	Therapeutics 01/2024 - 08/2011
2	Transcatheter Aortic Valve Replacement 02/2021 - 01/2021
1	Injections 02/2024
1	Enzyme Replacement Therapy 05/2023
1	Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Surgical Amputation (Amputations) 07/2020
1	Lasers (Laser) 06/2019
1	Artificial Pacemaker 05/2018
1	Limb Salvage 01/2018
1	Renal Dialysis (Hemodialysis) 01/2018